Alta Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Hold
831
0.09% 173
2025
Q4
$291K Sell
831
-240
-22% -$81.1K 0.11% 140
2025
Q3
$346K Hold
1,071
0.11% 157
2025
Q2
$417K Hold
1,071
0.15% 125
2025
Q1
$466K Buy
1,071
+300
+39% +$120K 0.2% 103
2024
Q4
$284K Buy
771
+171
+29% +$71.6K 0.18% 106
2024
Q3
$312K Hold
600
0.14% 86
2024
Q2
$325K Hold
600
0.16% 77
2024
Q1
$311K Hold
600
0.15% 81
2023
Q4
$283K Hold
600
0.15% 81
2023
Q3
$261K Hold
600
0.15% 79
2023
Q2
$267K Hold
600
0.15% 82
2023
Q1
$276K Hold
600
0.16% 76
2022
Q4
$308K Hold
600
0.18% 68
2022
Q3
$273K Buy
+600
New +$287K 0.17% 69

Other funds holding ELV

Alta Advisers's ELV Position: Q1 2026 in Review

Alta Advisers held its Elevance Health (ELV) position steady in Q1 2026 at 831 shares worth $243K. The position accounts for 0.09% of the portfolio, ranked #173.

Alta Advisers first reported a position in ELV in Q3 2022 and has held it in 15 quarters since. The position peaked at $466K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Alta Advisers held 831 shares of Elevance Health worth $243K as of Q1 2026.
  • Alta Advisers left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.09% of Alta Advisers's portfolio in Q1 2026, its #173 holding.
  • Alta Advisers first reported a position in Elevance Health in Q3 2022 and has held it in 15 quarters since.
  • Alta Advisers's Elevance Health position peaked at $466K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.